Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review
- PMID: 33637473
- PMCID: PMC7849433
- DOI: 10.1016/j.oooo.2021.01.028
Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review
Abstract
Objective: This systematic review aims to describe the value of saliva as a noninvasive sample for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in comparison with the current method for sample collection, the nasopharyngeal swab.
Study design: We conducted a systematic review of the literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. We searched in 5 databases (PubMed, Cochrane, EBSCO, Elsevier, and MEDLINE) and included articles published between December 2019 and July 2020.
Results: This review included 22 publications that met inclusion criteria, 17 of which were case series, 2 of which were case reports, and 3 of which were massive screenings. All articles compared saliva with nasopharyngeal swabs. The detection rate of SARS-CoV-2 in saliva was similar to that for nasopharyngeal swabs. The sensitivity ranged between 20% and 97%, and specificity ranged between 66% and 100%.
Conclusions: This systematic review found that saliva might be an appropriate, fast, painless, simple, and noninvasive sample for SARS-CoV-2 detection, making it ideal for massive screening of SARS-CoV-2 infection.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures
References
-
- World Health Organization (WHO). Coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed November 15, 2020.
-
- Parvez M, Jagirdar R, Purty R, et al. COVID‑19 pandemic: understanding the emergence, pathogenesis and containment (Review) World Acad Sci J. 2020;2:18.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
